Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
04:05pm, Thursday, 19'th Feb 2026
PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate
Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript
11:45am, Thursday, 19'th Feb 2026
Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
12:27am, Saturday, 14'th Feb 2026
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics
07:31pm, Thursday, 12'th Feb 2026
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics co
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates
06:31pm, Thursday, 12'th Feb 2026
10x Genomics (TXG) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.4 per share a year ago.
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
04:05pm, Thursday, 12'th Feb 2026
PLEASANTON, Calif., Feb. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year e
Financial Comparison: 10x Genomics (NASDAQ:TXG) vs. Zhongchao (NASDAQ:ZCMD)
02:59am, Thursday, 12'th Feb 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and Zhongchao (NASDAQ: ZCMD - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:01am, Thursday, 05'th Feb 2026
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
09:00am, Wednesday, 04'th Feb 2026
Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ --�
Torex Gold Resources (TSE:TXG) Shares Cross Above 200-Day Moving Average – Here’s Why
03:25am, Tuesday, 03'rd Feb 2026
Torex Gold Resources Inc. (TSE: TXG - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of C$58.31 and traded as
Head-To-Head Survey: 10x Genomics (NASDAQ:TXG) & Azenta (NASDAQ:AZTA)
01:46am, Saturday, 31'st Jan 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on th
SG Americas Securities LLC Sells 40,241 Shares of 10x Genomics $TXG
04:56am, Sunday, 25'th Jan 2026
SG Americas Securities LLC trimmed its stake in shares of 10x Genomics (NASDAQ: TXG) by 50.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commiss
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
04:05pm, Thursday, 22'nd Jan 2026
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
10:56am, Wednesday, 21'st Jan 2026
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Inscription Capital LLC Acquires 59,305 Shares of 10x Genomics $TXG
04:45am, Wednesday, 21'st Jan 2026
Inscription Capital LLC grew its holdings in shares of 10x Genomics (NASDAQ: TXG) by 161.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchang
